UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
iShares MSCI Germany ETF
EWG
$1.61B
| $12.4M | ﹤0.01% |
389,366
+176,358
| +83% | +$5.73M |
|
2827
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.29B
| $12.4M | ﹤0.01% |
73,388
+70,338
| +2,306% | +$12.2M |
|
2828
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$4.22B
| $12.4M | ﹤0.01% |
217,800
-81,500
| -27% | -$5.25M |
|
2829
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.53B
| $12.4M | ﹤0.01% |
324,581
+104,906
| +48% | +$4.19M |
|
2830
Travere Therapeutics
TVTX
$5.89B
| $12.4M | ﹤0.01% |
709,357
+383,122
| +117% | +$6.78M |
|
2831
Vanguard Russell 2000 Growth ETF
VTWG
$1.52B
| $12.3M | ﹤0.01% |
58,672
+5,518
| +10% | +$1.19M |
|
2832
Dr. Reddy's Laboratories
RDY
$10.1B
| $12.3M | ﹤0.01% |
780,822
+694,737
| +807% | +$10.4M |
|
2833
Alpha Metallurgical Resources
AMR
$1.93B
| $12.3M | ﹤0.01% |
61,594
+55,272
| +874% | +$12.4M |
|
2834
CALL
NXP Semiconductors
NXPI
$58.4B
| $12.3M | ﹤0.01% |
59,208
-2,500
| -4% | -$569K |
|
2835
PUT
Wheaton Precious Metals
WPM
$56.9B
| $12.3M | ﹤0.01% |
218,562
| – | – |
|
2836
argenx
ARGX
$54.8B
| $12.2M | ﹤0.01% |
19,900
+17,983
| +938% | +$10.5M |
|
2837
Trinity Industries
TRN
$2.47B
| $12.2M | ﹤0.01% |
348,455
+128,706
| +59% | +$4.65M |
|
|
ATXS
2838
DELISTED
Astria Therapeutics
ATXS
| $12.2M | ﹤0.01% |
1,365,992
+1,305,907
| +2,173% | +$13.9M |
|
2839
CALL
APA Corp
APA
$12.9B
| $12.2M | ﹤0.01% |
528,400
+510,400
| +2,836% | +$11.9M |
|
2840
Meritage Homes
MTH
$4.71B
| $12.2M | ﹤0.01% |
158,622
+81,550
| +106% | +$7.44M |
|
2841
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $12.2M | ﹤0.01% |
277,000
+69,300
| +33% | +$3.22M |
|
2842
CALL
BioNTech
BNTX
$22.9B
| $12.2M | ﹤0.01% |
106,900
+15,400
| +17% | +$1.76M |
|
2843
Pebblebrook Hotel Trust
PEB
$2.08B
| $12.2M | ﹤0.01% |
896,788
+95,562
| +12% | +$1.26M |
|
2844
Kura Sushi USA
KRUS
$590M
| $12.2M | ﹤0.01% |
134,140
+129,081
| +2,552% | +$12.1M |
|
2845
Hilltop Holdings
HTH
$2.25B
| $12.1M | ﹤0.01% |
424,241
+330,014
| +350% | +$10.3M |
|
2846
CALL
Edwards Lifesciences
EW
$51.5B
| $12.1M | ﹤0.01% |
163,900
+73,900
| +82% | +$5.17M |
|
2847
Helen of Troy
HELE
$671M
| $12.1M | ﹤0.01% |
202,275
+90,658
| +81% | +$6.03M |
|
2848
Evolus
EOLS
$488M
| $12.1M | ﹤0.01% |
1,093,405
+448,104
| +69% | +$6.3M |
|
2849
Brookdale Senior Living
BKD
$3.43B
| $12.1M | ﹤0.01% |
2,399,800
+678,074
| +39% | +$3.88M |
|
2850
Janux Therapeutics
JANX
$982M
| $12.1M | ﹤0.01% |
225,090
+170,896
| +315% | +$9.04M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.